Chemed CEO Sells $554K in Stock as Company Reports Soft Q4 Results
Chemed Corp President and CEO Kevin J. McNamara sold 1,500 shares of company stock on March 27, 2026, for about $554,055. The transaction occurred as the stock traded near its 52-week low and after the company reported fourth-quarter 2025 results that missed analyst expectations, prompting an RBC Capital downgrade driven by concerns over Roto-Roote…